Trials / Conditions / SCLC, Limited Stage
SCLC, Limited Stage
6 registered clinical trials studyying SCLC, Limited Stage — 6 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT NCT07309211 | The First Affiliated Hospital with Nanjing Medical University | — |
| Recruiting | Omitting CTV for Primary Tumor in LS-SCLC NCT07008716 | Sun Yat-sen University | Phase 3 |
| Recruiting | 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer NCT07508852 | Peking University First Hospital | Phase 1 / Phase 2 |
| Recruiting | Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCL NCT06911606 | Guangdong Provincial People's Hospital | Phase 2 |
| Recruiting | Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01) NCT06371482 | Hebei Medical University Fourth Hospital | Phase 2 |
| Recruiting | Lung Cancer Registry NCT04654364 | Arbeitsgemeinschaft medikamentoese Tumortherapie | — |